All rights reserved.
192.49
0.00 (0.00%)
Darden Restaurants (DRI) maintains a buy rating as demand remains resilient and management accelerates new store openings. Q3 saw 6% y/y sales growth, with adjusted same-restaurant sales potentially near 5% absent weather and promotion headwinds. Management raised FY2026 new restaurant guidance and expects further acceleration in FY2027, signaling strong confidence in demand trends.
DRI gains on menu innovation and strong sales, but inflation, high costs and weather disruptions continue to pressure margins.
For restaurants and food companies, the increasing adoption of GLP-1 drugs present both an opportunity and a threat to their businesses. About one in every eight U.S. adults is currently taking a GLP-1 drug, like Ozempic or Zepbound, according to the KFF Health Tracking Poll.
Darden Restaurants, Inc. (NYSE: DRI) on Thursday posted better-than-expected earnings for the third quarter.
Darden Restaurants, Inc. (DRI) Q3 2026 Earnings Call Transcript
Who's afraid of $4 gas? Not the executives of these restaurant and retail-store chains.
The results offered investors some reassurance, even as analysts said questions still linger over margins, costs, and consumer spending trends.
ORLANDO, Fla., March 19, 2026 /PRNewswire/ -- Darden Restaurants, Inc. (NYSE:DRI) today reported its financial results for the third quarter ended February 22, 2026.
ORLANDO, Fla., Feb. 3, 2026 /PRNewswire/ -- Darden Restaurants, Inc. ("Darden") (NYSE: DRI) today announced that it has completed its exploration of strategic alternatives for Bahama Breeze.
ORLANDO, Fla. , Dec. 18, 2025 /PRNewswire/ -- Darden Restaurants, Inc. (NYSE:DRI) today reported its financial results for the second quarter ended November 23, 2025.
